Conference abstractPublished 14 Sep 2016
Use of juvenile animal studies to support oncology medicine development in children
INFARMED-Autoridade Nacional do Medicamento e Produtos de Saude, Portugal; Lusofona University, Portugal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
When planning the pediatric development of any pharmaceutical, aspects that need to be taken into consideration include the understanding of potential for modified sensitivity vs. adults, unique toxicities or potential for effects on organ development. The need for early consideration of children has led to an increased focus on the relevance of nonclinical studies in juvenile animals (JAS). The immaturity of the developing organ may increase the potential for new target organs, modified activity or greater toxicity than has previously been seen in adults. While needing to screen for potential safety concerns associated to medicines use in children, avoiding useless studies and animal protection principles are strongly taken into consideration also. The need for animal studies for oncology drugs is in general a matter of controversy in particular for the most severe forms and the experience for JAS in advanced cancer patients is of importance. We intend to present a revision of results collected during the development of oncology pediatric medicines, towards pediatric use and build up the experience on utility of JAS. Also, a critical analysis of nonclinical information on all approved European Public Assessment Reports (EPARs: 1995âÂ?Â? 2014) concerning existence of JAS, pediatric therapeutic indication, and species and data from JAS in the nonclinical information on all approved pediatric investigation plans (PIPs) to support an indication in pediatric population (2007-2014). Further emphasis is placed on nonclinical support where PIPs refers to neonates and infants and the usefulness of such studies especially for tumors leading to short life expectancy.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Dinah Duarte”
